Literature DB >> 10695827

Renin-producing hepatoblastoma.

H Moritake1, A Taketomi, S Kamimura, Y Ikuno, Y Seo, T Fukuda, H Iguchi, J Okamura.   

Abstract

Renin-producing tumors of extrarenal origin are rare in children. An 8-year-old boy with hepatoblastoma and hypertension associated with a high plasma renin level is reported. After chemotherapy, the plasma renin level normalized and the hypertension spontaneously resolved. The patient underwent surgery, and a right trisegmentectomy of the liver and a partial resection of the second and third segments were performed. The tumor was as shown the source of renin by immunohistochemical study and reverse transcriptase-polymerase chain reaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10695827     DOI: 10.1097/00043426-200001000-00015

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Fractures in children with newly diagnosed hepatoblastoma.

Authors:  Alexander J Towbin; Fernanda D C Braojos Braga; Bin Zhang; James I Geller; Greg M Tiao; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2017-12-08

2.  Hypertension in a cohort of African children with renal tumours.

Authors:  G P Hadley; M Mars
Journal:  Pediatr Surg Int       Date:  2006-01-19       Impact factor: 1.827

3.  Severe hypertension and encephalopathy due to Renin-producing hepatoblastoma.

Authors:  Azita Tavasoli; Mitra Mehrazma; Nakisa Hooman; Ladan Afshar Khas
Journal:  Iran J Cancer Prev       Date:  2013

Review 4.  Hepatoblastoma in an 11-year-old: Case report and a review of the literature.

Authors:  Irina B Pateva; Rachel A Egler; Duncan S Stearns
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

5.  Dkk1 inhibits malignant transformation induced by Bmi1 via the β-catenin signaling axis in WB-F344 oval cells.

Authors:  Jinjun Ye; Le Xin; Jidong Liu; Tao Tang; Xing Bao; Yukuang Yan
Journal:  FEBS Open Bio       Date:  2021-06-09       Impact factor: 2.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.